title: Inhibition of protein kinase Akt1 by apoptosis signal-regulating kinase-1 (ASK1) is involved in apoptotic inhibition of regulatory volume increase.
abstract: Most animal cell types regulate their cell volume after an osmotic volume change. The regulatory volume increase (RVI) occurs through uptake of NaCl and osmotically obliged water after osmotic shrinkage. However, apoptotic cells undergo persistent cell shrinkage without showing signs of RVI. Persistence of the apoptotic volume decrease is a prerequisite to apoptosis induction. We previously demonstrated that volume regulation is inhibited in human epithelial HeLa cells stimulated with the apoptosis inducer. Here, we studied signaling mechanisms underlying the apoptotic inhibition of RVI in HeLa cells. Hypertonic stimulation was found to induce phosphorylation of a Ser/Thr protein kinase Akt (protein kinase B). Shrinkage-induced Akt activation was essential for RVI induction because RVI was suppressed by an Akt inhibitor, expression of a dominant negative form of Akt, or small interfering RNA-mediated knockdown of Akt1 (but not Akt2). Staurosporine, tumor necrosis factor-alpha, or a Fas ligand inhibited both RVI and hypertonicity-induced Akt activation in a manner sensitive to a scavenger for reactive oxygen species (ROS). Any of apoptosis inducers also induced phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) in a ROS-dependent manner. Suppression of (ASK1) expression blocked the effects of apoptosis, in hypertonic conditions, on both RVI induction and Akt activation. Thus, it is concluded that in human epithelial cells, shrinkage-induced activation of Akt1 is involved in the RVI process and that apoptotic inhibition of RVI is caused by inhibition of Akt activation, which results from ROS-mediated activation of ASK1.
authors.affiliation: Department of Cell Physiology, National Institute for Physiological Sciences, Okazaki 444-8585, Japan.
authors.forename: Muthangi
authors.initials: M
authors.lastname: Subramanyam
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Takahashi
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Hasegawa
authors.forename: Tatsuma
authors.initials: T
authors.lastname: Mohri
authors.forename: Yasunobu
authors.initials: Y
authors.lastname: Okada
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D048429:Cell Size; D004847:Epithelial Cells / Q000166:cytology; D006367:HeLa Cells; D006801:Humans; D048848:MAP Kinase Kinase Kinase 5 / Q000378:metabolism / Q000502:physiology*; D009995:Osmosis; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D017382:Reactive Oxygen Species; C494918:AKT1 protein, human; D051057:Proto-Oncogene Proteins c-akt; D048848:MAP Kinase Kinase Kinase 5; C482858:MAP3K5 protein, human